Clinical Trial Update: Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the SUPERIOR trial evaluating sildenafil for sustained pulmonary arterial hypertension after mitral valve surgery; trial terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diseases of the Mitral Valve
• Hypertension Pulmonary
• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Asan Medical Center | Conditions: Hypertension, Pulmonary, Diseases of Mitral Valve | Phase 2, Phase 3 | Status: TERMINATED